Anthropic

Explore the latest insights on Anthropic and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Anthropic’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

CDE Includes Beijing Toll Biotech's TollB‑001 Tablets in Rare Disease Pilot Scheme – Novel Oral TLR8 Inhibitor Targets Systemic Sclerosis with First Specific Treatment Potential
CompanyDrug

CDE Includes Beijing Toll Biotech’s TollB‑001 Tablets in Rare Disease Pilot Scheme – Novel Oral TLR8 Inhibitor Targets Systemic Sclerosis with First Specific Treatment Potential

According to the latest public notice from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA), TollB‑001 Tablets from Beijing Toll Biotech Co., Ltd. have been…

CSPC Pharmaceutical Initiates Phase II Trial of SYH2069 – Novel Long‑Acting GLP‑1R/GIPR Dual Agonist with Dual‑Biased Activity for Adult Type 2 Diabetes

CSPC Pharmaceutical Initiates Phase II Trial of SYH2069 – Novel Long‑Acting GLP‑1R/GIPR Dual Agonist with Dual‑Biased Activity for Adult Type 2 Diabetes

GenScript Biotech Collaborates with Lilly TuneLab – Pairing Large‑Scale Wet‑Lab Validation with Eli Lilly's AI/ML Drug Discovery Platform

GenScript Biotech Collaborates with Lilly TuneLab – Pairing Large‑Scale Wet‑Lab Validation with Eli Lilly’s AI/ML Drug Discovery Platform

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Novo Nordisk and Anthropic Announce AI Collaboration – Claude Science to Accelerate Drug Discovery and AI‑Driven Software Development
CompanyDeals

Novo Nordisk and Anthropic Announce AI Collaboration – Claude Science to Accelerate Drug Discovery and AI‑Driven Software Development